Jpmorgan Chase & Co »

Bridgebio Pharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.9M 220k 40.37
2023-09-30 $5.6M 214k 26.37
2023-06-30 $3.9M 226k 17.20
2023-03-31 $64M 198k 325.07
2022-12-31 $4.0M 529k 7.62
2022-06-30 $3.5M 384k 9.08
2022-03-31 $8.3M 748k 11.07
2021-12-31 $26M 1.5M 16.69
2021-03-31 $90M 1.5M 61.90
2020-12-31 $98M 1.4M 72.29
2020-09-30 $48M 1.3M 37.10
2020-06-30 $33M 1.0M 32.61
2020-03-31 $27M 923k 29.00
2019-12-31 $21M 593k 35.05
2019-09-30 $13M 589k 21.47
2019-06-30 $25M 917k 27.37